Linked Life Data

21397482

Source:http://linkedlifedata.com/resource/pubmed/id/21397482

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2011-4-25
pubmed:databankReference
pubmed:abstractText
Indacaterol is a novel, inhaled, ultra-long-acting ?(2)-agonist bronchodilator for maintenance use in patients with COPD. The aim of this paper is to assess the effect of indacaterol on dyspnoea and health status, using pooled study data to evaluate the relative efficacy of indacaterol and existing bronchodilators.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1532-3064
pubmed:author
pubmed:copyrightInfo
Copyright © 2011 Elsevier Ltd. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
105
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
892-9
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD.
pubmed:affiliation
Division of Clinical Science, St George's University of London, Cranmer Terrace, London SW17 0RE, UK. pjones@sgul.ac.uk
pubmed:publicationType
Journal Article, Randomized Controlled Trial